Commonwealth Equity Services’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-1,342
Closed -$329K 3843
2022
Q3
$329K Buy
1,342
+87
+7% +$23.5K ﹤0.01% 2749
2022
Q2
$310K Buy
1,255
+80
+7% +$21.6K ﹤0.01% 2813
2022
Q1
$389K Buy
1,175
+3
+0.3% +$923 ﹤0.01% 2739
2021
Q4
$420K Sell
1,172
-493
-30% -$167K ﹤0.01% 2678
2021
Q3
$541K Buy
1,665
+361
+28% +$122K ﹤0.01% 2415
2021
Q2
$406K Sell
1,304
-10
-0.8% -$3.07K ﹤0.01% 2633
2021
Q1
$418K Sell
1,314
-362
-22% -$116K ﹤0.01% 2473
2020
Q4
$543K Sell
1,676
-2,952
-64% -$817K ﹤0.01% 2104
2020
Q3
$1.28M Buy
4,628
+2,729
+144% +$786K ﹤0.01% 1348
2020
Q2
$458K Buy
1,899
+87
+5% +$17.5K ﹤0.01% 1947
2020
Q1
$263K Sell
1,812
-1,181
-39% -$196K ﹤0.01% 2164
2019
Q4
$510K Sell
2,993
-2,172
-42% -$403K ﹤0.01% 1903
2019
Q3
$918K Sell
5,165
-889
-15% -$192K ﹤0.01% 1411
2019
Q2
$1.58M Buy
6,054
+1,453
+32% +$386K 0.01% 1085
2019
Q1
$1.31M Sell
4,601
-875
-16% -$291K 0.01% 1131
2018
Q4
$1.78M Buy
5,476
+1,881
+52% +$653K 0.01% 906
2018
Q3
$1.62M Buy
3,595
+378
+12% +$149K 0.01% 1033
2018
Q2
$1.32M Buy
3,217
+124
+4% +$44.9K 0.01% 1132
2018
Q1
$900K Buy
3,093
+145
+5% +$36.7K ﹤0.01% 1314
2017
Q4
$552K Buy
2,948
+624
+27% +$117K ﹤0.01% 1620
2017
Q3
$392K Buy
2,324
+11
+0.5% +$1.66K ﹤0.01% 1793
2017
Q2
$331K Buy
2,313
+465
+25% +$62.5K ﹤0.01% 1849
2017
Q1
$231K Sell
1,848
-486
-21% -$56.3K ﹤0.01% 2049
2016
Q4
$263K Buy
2,334
+200
+9% +$23.2K ﹤0.01% 1858
2016
Q3
$274K Sell
2,134
-161
-7% -$19.3K ﹤0.01% 1780
2016
Q2
$251K Sell
2,295
-130
-5% -$12.9K ﹤0.01% 1792
2016
Q1
$230K Buy
+2,425
New +$205K ﹤0.01% 1817

Other funds holding ABMD

Commonwealth Equity Services's ABMD Position: Q4 2022 in Review

Commonwealth Equity Services sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,342 shares — an estimated $329K sold.

Commonwealth Equity Services first reported a position in ABMD in Q1 2016 and held it in 27 quarters. The position peaked at $1.78M in Q4 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Commonwealth Equity Services reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Commonwealth Equity Services sold 1,342 Abiomed Inc shares in Q4 2022, an estimated $329K.
  • Commonwealth Equity Services first reported a position in Abiomed Inc in Q1 2016 and held it in 27 quarters.
  • Commonwealth Equity Services's Abiomed Inc position peaked at $1.78M in Q4 2018.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Commonwealth Equity Services's 13F filing for Q4 2022, filed 7 Feb 2023.